After a four-month investigation, Nature Medicine has decided to pull a viral study that linked early-day PD-1/chemo ...
A new randomized clinical trial from investigators at Mass General Brigham’s Neuroscience Institute and Department of ...
Part C domestic enrollment is underway at three clinical sites in the U.S.CHICAGO, June 25, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc.
A new randomized clinical trial from investigators at Mass General Brigham's Neuroscience Institute and Department of ...
The products are far from a proven sleep treatment.
High-dose DHA effectively increased brain levels in older adults at Alzheimer's risk, but did not lead to cognitive or ...
By 2050, scientists estimate that antibiotic-resistant infections will be associated with more than eight million deaths ...
Researchers at the University of Pennsylvania analyzed data from 111,646 women and found that those who used GLP-1 receptor ...
There has been growing recognition that gut health may play a role in Parkinson’s disease—a brain disorder. This article ...
Insmed remains a Strong Buy as ARIKAYCE, TPIP Phase 3 progress and 44% YoY BRINSUPRI growth drive upside. Click here to read ...